TEA Fee For Expedited Review, Dedicated Staff Increase Suggested
This article was originally published in The Rose Sheet
Executive Summary
FDA should consider establishing a voluntary fee option for expedited reviews of OTC monograph time and extent applications, Ciba Specialty Chemicals recommends in April 13 comments to the agency
You may also be interested in...
FDA To Review Piroctone Olamine For OTC Dandruff Monograph Status
FDA is seeking safety and efficacy data on piroctone olamine for use as a single active ingredient in dandruff control products, the agency announced in a Federal Register 1notice Feb. 18
FDA Draft Guidance Clarifies OTC Time & Extent Applications
Time & extent applications for OTC monograph eligibility should describe adverse event reporting systems in countries outside the U.S. where active ingredients have been marketed, according to an FDA draft guidance
Triclosan Antigingivitis/Antiplaque Monograph Status Sought By Ciba
Ciba Specialty Chemicals requests that FDA include triclosan in its upcoming OTC monograph for antigingivitis/antiplaque oral care products in a recently-filed application